The National Institute for Health and Care Excellence (NICE) have published new or updated guidance for the month of June 2020. This month is one guideline, one medtech innovation briefing and one evidence summary related to COVID-19 that impact upon primary care.
The Joint replacement (primary): hip, knee and shoulder guideline has been published. It covers care before, during and after a planned knee, hip or shoulder replacement. It includes recommendations to ensure that people are given full information about their options for surgery, including anaesthesia. It offers advice for healthcare professionals on surgical procedures and ensuring safety during operations. It also offers guidance on providing support and rehabilitation before and after surgery.
The FibroScan for assessing liver fibrosis and cirrhosis in primary care medtech innovation briefing has been published. This briefing notes that the intended place in therapy would be in primary care for people with liver fibrosis or cirrhosis and recognises that the technology is already used extensively in specialised care settings. It is also noted that it is unclear if every primary care centre would be able to support a FibroScan clinic.
The COVID-19 rapid evidence summary: vitamin D for COVID-19 evidence summary has been published. It notes that there is no evidence to support taking vitamin D supplements to specifically prevent or treat COVID‑19. However, it is also noted the everyone should continue to follow UK Government advice on daily vitamin D supplementation to maintain bone and muscle health during the COVID‑19 pandemic.
Action: Clinicians should be aware of this month's new guidance and implement any necessary changes to practice.
|« Drug Safety Update - June 2020||CKS Updates - June 2020 »|